RAC 0.60% $1.69 race oncology ltd

General Comments / Chat, page-4811

  1. 8,518 Posts.
    lightbulb Created with Sketch. 1397
    The BC trial recently announced will be both for cancer efficacy and cardioprotection. It's not only for cardioprotection.
    Cardioprotection is a much easier sell than FTO inhibition because all oncologists are aware of the cardiotoxicity problem, whereas FTO's role is relatively new and requires some education of oncologists.

    RAC says that the new trial is in response to doctors' requests already received after the recent preclinical results.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.